Inpatient Treatment for Herpes Zoster Ophthalmicus
The preferred inpatient treatment for herpes zoster ophthalmicus is intravenous acyclovir at a dose of 10 mg/kg body weight three times daily for 10-14 days, followed by oral valacyclovir 1 g three times daily for 4-6 weeks. 1
Antiviral Therapy
First-Line Treatment
- IV Acyclovir: 10 mg/kg body weight every 8 hours for 10-14 days 1
Transition to Oral Therapy
After IV treatment course, transition to:
- Valacyclovir: 1 g three times daily for 4-6 weeks (for patients able to receive adult dosing) 1
- Alternative: Oral acyclovir 20 mg/kg body weight for 4-6 weeks 1
For Patients Not Responding to Acyclovir
- Foscarnet: 40-60 mg/kg body weight IV per dose three times daily for 7-10 days 1
Ophthalmologic Management
- Mandatory ophthalmology consultation: Involvement of an experienced ophthalmologist is strongly recommended for management of varicella zoster virus eye infections 1
- Regular follow-up: Should include interval history, visual acuity measurement, and slit-lamp biomicroscopy 1
Special Considerations
Complications Management
- Corneal involvement: Monitor for pseudodendrites, keratitis, corneal scarring, and vascularization 1
- Intraocular complications: Watch for iritis/uveitis, sectoral iris atrophy, and secondary glaucoma 1
- Late sequelae: Monitor for dry eye and corneal anesthesia with neurotrophic keratitis 1
Dosing Considerations
- Renal impairment: Dose adjustment required for patients with impaired renal clearance 1
- Immunocompromised patients: May require more aggressive treatment with higher doses or longer duration 1
Alternative Oral Regimens (if IV therapy not feasible)
For less severe cases or when IV therapy is not possible:
- Valacyclovir: 1000 mg every 8 hours for 7 days 1, 2
- Advantage: Simpler dosing schedule (three times daily) with similar efficacy to acyclovir 2
- Acyclovir: 800 mg five times daily for 7-10 days 1, 3, 4
- Famciclovir: 500 mg three times daily for 7 days 1
Important Clinical Pearls
- Early treatment is crucial: Starting antiviral therapy within 72 hours of rash onset significantly reduces the risk of severe ocular complications 3, 5
- Avoid topical corticosteroids in acute phase as they may potentiate viral infection 1
- Topical antivirals alone have not been shown to be helpful in treating VZV conjunctivitis but may be used as additive treatment in unresponsive patients 1
- Chronic disease may require prolonged treatment with dose adjustment according to clinical response 1
- Oral valacyclovir may be an effective alternative to IV acyclovir in selected immunocompetent patients with HZO-induced optic neuritis 6
Remember that prompt initiation of appropriate antiviral therapy is essential to reduce morbidity, prevent vision loss, and minimize the risk of post-herpetic neuralgia.